|
Volumn 117, Issue 1, 2009, Pages 197-198
|
Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
PACLITAXEL;
ANAMNESIS;
ASPIRATION BIOPSY;
AUTOIMMUNITY;
BREAST BIOPSY;
BREAST CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER STAGING;
CANCER SURGERY;
CLINICAL FEATURE;
DEPIGMENTATION;
DESQUAMATION;
DRUG RESPONSE;
DRUG WITHDRAWAL;
ERYTHEMA;
HAND DISEASE;
HUMAN;
HYPOPIGMENTATION;
IMMUNOTHERAPY;
INTRADUCTAL CARCINOMA;
INVASIVE CARCINOMA;
LETTER;
LOW DRUG DOSE;
LYMPH NODE DISSECTION;
MULTIPLE CYCLE TREATMENT;
PARTIAL MASTECTOMY;
PHYSICAL EXAMINATION;
PRIORITY JOURNAL;
PROGNOSIS;
SKIN EXAMINATION;
SKIN TOXICITY;
UNSPECIFIED SIDE EFFECT;
VITILIGO;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FEMALE;
HUMANS;
NEOADJUVANT THERAPY;
VITILIGO;
|
EID: 69049105901
PISSN: 01676806
EISSN: 15737217
Source Type: Journal
DOI: 10.1007/s10549-008-0074-6 Document Type: Letter |
Times cited : (2)
|
References (9)
|